pharmaphorum

APRIL 30, 2021

Turning words into actions with patient engagement. Boehringer Ingelheim’s Carinne Brouillon tells us how the company co-created its recent Global Patient Partnership Summit with patients. “A How the patient voice is becoming vital for drug approval. Building honest dialogue with patient advocates.

Marketing 98

Marketing Sales Regulation Drugs 98

STAT News

JANUARY 20, 2023

On Target is a recurring feature from STAT that dives deep into the most promising drug targets in oncology. Finding such biomarkers is critical to developing treatments that can kill the cancer without also killing the patient. Read the rest…

Scientist 98

Scientist Development Drugs Research 98

pharmaphorum

DECEMBER 17, 2021

Read on for a look at some of the biggest stories from Frontiers Health, how digital is making healthcare more patient-friendly and key ways to optimise decentralised clinical trials. A multi-platform approach: the future of patient services. Accelerating patient engagement in the digital health era.

Clinical Trials 98

Clinical Trials Clinical Trials Medicine DNA 98

pharmaphorum

NOVEMBER 8, 2022

Ask nearly any pharma company these days if they’re patient-centric, and you’ll probably get an answer in the affirmative. But dig deeper, and you might find that patient centricity means a lot of different things to a lot of different people. Why patient centricity in life sciences now?”

Life Science 52

Life Science Pharma Companies Branding Development 52

Drug Channels

JANUARY 9, 2024

Read on for my deep dive into these two therapeutic categories. I also highlight recent research that raises troubling questions about the patient impact of these ever-growing exclusion lists. There are also unusual formulary developments for insulin products, many of which experienced massive list price cuts for 2024.

Insulin 90

Insulin Pharmacy Drugs Production 90

STAT News

AUGUST 17, 2022

On Target is a recurring feature from STAT that dives deep into the most promising drug targets in oncology.  With the right biomarker, scientists can find cancers earlier, monitor a treatment’s progress, or predict if a certain therapy will work for a given patient. Continue to STAT+ to read the full story…

RNA 98

RNA DNA Protein Scientist 98

pharmaphorum

NOVEMBER 17, 2022

Strong patient partnerships are more important than ever. That way, everything we do for patients, we do with patients. Caroline Averius, senior global patient partnership director, Roche. The post The future of clinical research in neurology must be driven by community voices appeared first on.

Clinical Research 82

Clinical Research Research Clinical Trials Clinical Trials 82

pharmaphorum

OCTOBER 1, 2021

This issue assesses European pharma’s approach to strategic communications, the future of pharma commercialisation, communications gaps with patients and, with the pandemic continuing to cast a long shadow over healthcare, how to maximise the effectiveness of HCP engagement. Closing pharma’s communication gap with patients.

Doctors 52

Doctors Doctor Marketing Branding 52

pharmaphorum

JANUARY 8, 2021

How can pharma improve the patient-centricity of its trials during COVID-19 and beyond? Experts from across the sector give their thoughts on the key approaches and technologies that are driving patient engagement forward. The post True patient-focused research through decentralised and hybrid trials appeared first on.

Trials 105

Trials Research Clinical Trials Clinical Trials 105

pharmaphorum

MAY 6, 2022

Read on to find out how diverse viewpoints are reshaping value, the importance of making patient centricity a reality, and much more. How do we make patient centricity a reality? Giving patients a seat at the table is essential as real-time patient data gains prominence. Read Deep Dive: Market Access in full.

Marketing 52

Marketing Life Science Regulation Development 52

pharmaphorum

NOVEMBER 16, 2022

Recognising patients as key stakeholders and embedding the patient voice, in a meaningful way, into every stage of the medicine’s development process is gradually being recognised as a means to deliver value to both life science companies and to patients and their care partners.

Life Science 52

Life Science Clinical Trials Clinical Trials Medicine 52

pharmaphorum

MARCH 8, 2021

Emma Sutcliffe from NexGen Healthcare Communications looks at how patient insights can bring the invisible challenges of living with a rare condition into plain view. In January, for example the UK Government published their policy paper outlining a ‘Rare Diseases Framework’ which pledges to: Ensure patients get the right diagnosis faster.

Research 110

Research Drugs Development 110

Drug Channels

MAY 2, 2023

In my most recent video webinar , I explored how the rapid expansion of patient-paid prescriptions—via cash-pay pharmacies and discount card vendors—is transforming the prescription market. Below, I follow the dollar when a patient uses a discount card to pay for a generic drug prescription. retail pharmacy pricing. and 12.4.3.

Pharmacy 75

Pharmacy Generic Drugs Drugs Marketing 75

pharmaphorum

JULY 7, 2022

As this issue’s contributors discuss, by working together pharma companies and healthcare providers can significantly enhance oncology treatment for patients. Read Deep Dive: Oncology in full. Subscribe to future issues of Deep Dive. The post Deep Dive: Oncology 2022 appeared first on.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

pharmaphorum

NOVEMBER 9, 2022

Patients have a unique first-hand insight into their condition, which can be a valuable asset in the design, delivery, and publication of real-world studies, as Envision Pharma Group’s Dr Dawn Lobban and Vitaccess’ Dr Catherine Bottomley discuss.

Clinical Trials 52

Clinical Trials Clinical Trials Life Science Trials 52

pharmaphorum

DECEMBER 3, 2021

From calls for more diversity in age, gender, and ethnic groups, to more consideration for lifestyle and cultural differences, trials need to ensure they represent the key population of interest and identify a greater range of opportunities to maximise benefits for both patients and pharma. Effectively, the detail and the differences matter.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Development 52

pharmaphorum

DECEMBER 2, 2022

Read on for key stories from this year’s Frontiers Health conference in Italy, unlocking the promise of patient support programmes in oncology, supercharging communications with modular content, and much more. Unlocking the promise of patient support programmes in oncology. Read Deep Dive: Digital Health 2022 in full.

Pharma Companies 52

Pharma Companies Vaccination Vaccine Marketing 52

Drug Channels

JUNE 22, 2023

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. Below, I follow the dollar when a patient uses a discount card to pay for a generic drug prescription. retail pharmacy pricing. and 12.4.3.

Pharmacy 89

Pharmacy Generic Drugs Drugs Marketing 89

pharmaphorum

NOVEMBER 15, 2022

Value-based healthcare (VBHC) is gaining traction across the industry for its potential to improve patient care by standardising clinical and patient outcomes. But there’s a high degree of variability in patients’ outcomes following the procedure, and some patients may benefit from it more than others. billion USD.

52

52

pharmaphorum

FEBRUARY 24, 2022

Fuelled by advancements in technology and computing, R&D in life sciences is undergoing a fundamental transformation that puts patients at the heart of research. Rare disease communities are among the most empowered patient populations. AXON’s Emma Lemon discusses the value of engaging rare disease patients, HCPs, and caregivers.

Development 52

Development Research Life Science Marketing 52

pharmaphorum

MAY 21, 2021

When it comes to ultra-rare diseases, the smaller the patient population, the bigger the challenges. The company prides itself on a patient-centric approach to treatment but there can be significant hurdles in patients accessing potentially life-changing treatments.

Gene Therapy 118

Gene Therapy Gene Clinical Trials Clinical Trials 118

Drug Channels

APRIL 3, 2024

Read on for my deep dive into these two therapeutic categories. I also highlight recent research that raises troubling questions about the patient impact of these ever-growing exclusion lists. .* There are also unusual formulary developments for insulin products, many of which experienced massive list price cuts for 2024.

Insulin 52

Insulin Pharmacy Drugs Production 52

pharmaphorum

NOVEMBER 23, 2022

In a time of increasing cost pressures, limited resource capacity, and heightened demand for new treatments, Health Technology Assessments (HTAs) play a vital role in evaluating whether new interventions will provide sufficient patient benefits to justify the cost to the health service.

52

52

pharmaphorum

DECEMBER 6, 2021

How the combination treatment challenge impacts patients. Access to medicines attracts a great deal of interest from patients, clinicians, and the public and there have been significant advances in drug development in recent years which looks set to continue.

Medicine 52

Medicine Development Drugs 52

pharmaphorum

NOVEMBER 22, 2021

Patients want to be part of the healthcare conversation and genuinely heard by those who make the final decisions, but pharma does not always understand how to connect with patients. “A A lot of pharmaceutical companies are trying to get their heads around how to include patients in the conversation,” says Natalie.

52

52

pharmaphorum

JANUARY 13, 2021

Trial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as a result. The next step is ensuring the industry does not regress to old ways of working once the pandemic is over, say Karen McIntyre and Allyson Small.

Clinical Trials 75

Clinical Trials Clinical Trials Trials Regulation 75

pharmaphorum

SEPTEMBER 22, 2022

Next generation patient engagement and enriched insights. As person generated health data becomes more widely recognised, a new whitepaper from Evidation explores how patient insights impact clinical decision making. Read Deep Dive: Communications & Commercialisation 2022 in full.

Gene Therapy 52

Gene Therapy Marketing Gene Sales 52

pharmaphorum

NOVEMBER 21, 2022

Improving patient outcomes starts by listening to and understanding their needs. Research Partnership’s Living With reports give a voice to patients living with a variety of chronic conditions, by reporting on quantitative research undertaken directly with them. Women living with endometriosis.

Research 52

Research 52

pharmaphorum

NOVEMBER 19, 2021

Marie Emms, vice president of site and patient participation at Syneos Health, tells us technology helped increase patient enrolment, improve diversity and inclusion, and boost retention rates for clinical trials after the pandemic. Still, she says a lot needs to be done to continue this upward trajectory.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Development 52

pharmaphorum

NOVEMBER 20, 2020

While the pandemic has been a global tragedy it has also forced health systems to rethink the way they operate in order to minimise risks to both patients and healthcare staff. The post What will the digital health ecosystem look like post-COVID?

120

120

pharmaphorum

SEPTEMBER 17, 2020

New survey reveals patients’ changing opinions of pharma. Exclusive research from WEGO Health has revealed patients’ changing attitudes towards the pharma industry and how they want to see companies improve. The tools and techniques making virtual patient simulations more realistic than ever. Cutting through the noise for HCPs.

Marketing 52

Marketing Sales Research Development 52

pharmaphorum

JANUARY 22, 2021

Research Partnership’s Emilie Braund and Harrison Gaiger dig down into the top insights pharma companies can harness to make their patient support programmes as powerful as possible. The pandemic has undoubtedly disrupted the healthcare landscape and amplified the complex factors that influence and shape patient journeys.

Compliance 77

Compliance Pharma Companies Research Marketing 77

pharmaphorum

DECEMBER 18, 2020

OPEN Health’s Richard Jones and Sumira Riaz assess the pandemic’s implications for understanding patients’ experiences and how the pharma industry can support them. The way in which patients make their way through the healthcare system has shifted enormously, bringing disruption to the patient experience.

Vaccination 52

Vaccination Vaccine 52

World of DTC Marketing

OCTOBER 30, 2020

One of the services we often provide for clients is a deep-dive web analytics report. However, in a deeper dive, the traffic is coming from organic search, not paid search. I recommend a test of ad placement using insights on current patients vs. programmatic. Here are some examples. This, in my opinion, is a mistake.

Branding 279

Branding Marketing Development Research 279

pharmaphorum

NOVEMBER 24, 2021

Patient engagement in pharma is evolving, with some companies doing it better than others. Envision Pharma Group’s Dawn Lobban and Sarah Avent discuss the need to engage with patients at every level for holistic inclusion of the patient voice in order for pharma to become truly patient-centric.

Medicine 58

Medicine Development Production Drugs 58

pharmaphorum

OCTOBER 20, 2022

In mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLennan travelled to Nice for the Reuters Pharma event. This special episode includes a conversation recorded on-site with Nicole, Eloise, Virtual Science AI CEO Thomas Hughes, and VSAI VP of global patient affairs Geraldine Reilly.

Life Science 97

Life Science Development 97

pharmaphorum

NOVEMBER 25, 2021

We have continued to see over the past 20 years, the nature of technological capability and company therapeutic focus shift from high-volume, low-cost therapy areas, such as diabetes and depression, towards high-value medicines targeted at niche patient populations. The post Time for a new model in patient access appeared first on.

Gene Therapy 52

Gene Therapy Genetics Medicine Gene 52